MX369464B - Espumas liofilizadas de polímeros absorbibles que contienen bloques de extremo. - Google Patents

Espumas liofilizadas de polímeros absorbibles que contienen bloques de extremo.

Info

Publication number
MX369464B
MX369464B MX2017015577A MX2017015577A MX369464B MX 369464 B MX369464 B MX 369464B MX 2017015577 A MX2017015577 A MX 2017015577A MX 2017015577 A MX2017015577 A MX 2017015577A MX 369464 B MX369464 B MX 369464B
Authority
MX
Mexico
Prior art keywords
foams
end block
absorbable polymers
containing absorbable
lyophilized foams
Prior art date
Application number
MX2017015577A
Other languages
English (en)
Other versions
MX2017015577A (es
Inventor
Donners Jackie
Wisnudel Marc
Timmer Mark
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of MX2017015577A publication Critical patent/MX2017015577A/es
Publication of MX369464B publication Critical patent/MX369464B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/36—After-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/048—Elimination of a frozen liquid phase
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/048—Elimination of a frozen liquid phase
    • C08J2201/0482—Elimination of a frozen liquid phase the liquid phase being organic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2205/00—Foams characterised by their properties
    • C08J2205/02—Foams characterised by their properties the finished foam itself being a gel or a gel being temporarily formed when processing the foamable composition
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2205/00—Foams characterised by their properties
    • C08J2205/04—Foams characterised by their properties characterised by the foam pores
    • C08J2205/05—Open cells, i.e. more than 50% of the pores are open
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2207/00—Foams characterised by their intended use
    • C08J2207/10—Medical applications, e.g. biocompatible scaffolds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/16—Biodegradable polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
    • C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Se describen espumas absorbibles, soluciones liofilizantes y procesos de liofilización y recocido novedosos; las espumas se elaboran a partir de copolímeros de glicólido y épsilon-caprolactona; las espumas son útiles en dispositivos médicos implantables o como dispositivos médicos implantables.
MX2017015577A 2015-06-02 2016-05-24 Espumas liofilizadas de polímeros absorbibles que contienen bloques de extremo. MX369464B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/728,226 US9896560B2 (en) 2015-06-02 2015-06-02 Lyophilized foams of end block containing absorbable polymers
PCT/US2016/033894 WO2016196076A1 (en) 2015-06-02 2016-05-24 Lyophilized foams of end block- containing absorbable polymers

Publications (2)

Publication Number Publication Date
MX2017015577A MX2017015577A (es) 2018-03-27
MX369464B true MX369464B (es) 2019-11-08

Family

ID=56116565

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017015577A MX369464B (es) 2015-06-02 2016-05-24 Espumas liofilizadas de polímeros absorbibles que contienen bloques de extremo.

Country Status (10)

Country Link
US (2) US9896560B2 (es)
EP (1) EP3302597A1 (es)
JP (1) JP6786525B2 (es)
CN (1) CN107666915A (es)
AU (1) AU2016270495B9 (es)
BR (1) BR112017025810A2 (es)
CA (1) CA2988080A1 (es)
MA (1) MA44204A (es)
MX (1) MX369464B (es)
WO (1) WO2016196076A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109251388B (zh) * 2018-07-04 2020-12-01 湖北祥源新材科技股份有限公司 具有耐高温的交联聚烯烃发泡材料及其制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605730A (en) 1982-10-01 1986-08-12 Ethicon, Inc. Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same
US4700704A (en) 1982-10-01 1987-10-20 Ethicon, Inc. Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same
EP0261470B1 (en) * 1986-09-23 1993-05-05 American Cyanamid Company Bioabsorbable coating for a surgical article
US4788979A (en) * 1986-09-23 1988-12-06 American Cyanamid Company Bioabsorbable coating for a surgical article
ATE105714T1 (de) * 1988-03-24 1994-06-15 American Cyanamid Co Bioresorbierbare beschichtung für chirurgische artikel.
GR1002095B (en) * 1990-02-06 1995-12-28 Ethicon Inc Segmented copolymers of e-caprolactone and glycolide
US5133739A (en) 1990-02-06 1992-07-28 Ethicon, Inc. Segmented copolymers of ε-caprolactone and glycolide
US5102983A (en) 1990-04-02 1992-04-07 United States Surgical Corporation Process for preparing foamed, bioabsorbable polymer particles
US5468253A (en) 1993-01-21 1995-11-21 Ethicon, Inc. Elastomeric medical device
US5431679A (en) 1994-03-10 1995-07-11 United States Surgical Corporation Absorbable block copolymers and surgical articles fabricated therefrom
US5633343A (en) * 1995-06-30 1997-05-27 Ethicon, Inc. High strength, fast absorbing, melt processable, gycolide-rich, poly(glycolide-co-p-dioxanone) copolymers
US5747637A (en) * 1995-09-07 1998-05-05 Mitsui Toatsu Chemicals, Inc. Bioabsorbable polymer and process for preparing the same
US6068920A (en) * 1997-09-04 2000-05-30 Mitsui Chemicals, Inc. Random-block copolymer and monofilament thereof
JPH11181077A (ja) * 1997-09-04 1999-07-06 Mitsui Chem Inc ランダム−ブロック共重合体及びそのモノフィラメント
US5854383A (en) 1997-10-06 1998-12-29 Ethicon, Inc. Aliphatic polyesters of trimethylene carbonate epsilon-caprolactone and glycolide
EP0908142B1 (en) 1997-10-10 2006-05-03 Ethicon, Inc. Braided suture with improved knot strength and process to produce same
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
US6306424B1 (en) * 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6325810B1 (en) 1999-06-30 2001-12-04 Ethicon, Inc. Foam buttress for stapling apparatus
US6333029B1 (en) 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6599323B2 (en) 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
KR100408458B1 (ko) 2000-12-27 2003-12-06 한국과학기술연구원 생분해성 글리콜라이드/ε-카프로락톤 공중합체로부터 제조된 조직공학용 다공성 지지체
JP4879404B2 (ja) * 2001-03-21 2012-02-22 エシコン・インコーポレイテッド 組織の修復または再生のための多孔質組織骨格形成材料
KR100453130B1 (ko) 2001-11-21 2004-10-15 한국과학기술연구원 구조적 배열이 일정한 생분해성 락타이드(글리콜라이드또는 락타이드/글리콜라이드)/ε-카프로락톤 멀티블록공중합체 및 이의 제조 방법
US6712850B2 (en) * 2001-11-30 2004-03-30 Ethicon, Inc. Porous tissue scaffolds for the repair and regeneration of dermal tissue
US7148315B2 (en) 2002-10-23 2006-12-12 Ethicon, Inc. Monomer addition techniques to control manufacturing of bioabsorbable copolymers
US7435789B2 (en) 2003-01-31 2008-10-14 Poly-Med, Inc. Crystalline high-compliance glycolide copolymers and applications thereof
EP1555278A1 (en) 2004-01-15 2005-07-20 Innocore Technologies B.V. Biodegradable multi-block co-polymers
US8945598B2 (en) * 2005-12-29 2015-02-03 Cordis Corporation Low temperature drying methods for forming drug-containing polymeric compositions
US20080033540A1 (en) * 2006-08-01 2008-02-07 Yunbing Wang Methods to prepare polymer blend implantable medical devices
US20090004271A1 (en) 2007-06-29 2009-01-01 Brown Laura J Morselized foam for wound treatment
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
US8278409B2 (en) 2008-04-22 2012-10-02 Ethicon, Inc. Copolymers of epsilon-caprolactone and glycolide for melt blown nonwoven applications
US20100021527A1 (en) * 2008-07-25 2010-01-28 Chunlin Yang Collagen-related peptides and uses thereof and hemostatic foam substrates
US20100247598A1 (en) * 2009-03-31 2010-09-30 Shetty Dhanuraj S Thick foams for biomedical application and methods of making
US20130236499A1 (en) * 2012-03-12 2013-09-12 Sasa Andjelic Segmented, Semicrystalline Poly(Lactide-co-epsilon-Caprolactone) Absorbable Copolymers
US20140275467A1 (en) * 2013-03-15 2014-09-18 Ethicon, Inc. Polylactone Polymers Prepared from Monol and Diol Polymerization Initiators Processing Two or More Carboxylic Acid Groups
US10086109B2 (en) * 2015-06-02 2018-10-02 Ethicon, Inc. Absorbable medical devices based on novel films and foams made from semi-crystalline, segmented copolymers of lactide and epsilon-caprolactone exhibiting long term absorption characteristics

Also Published As

Publication number Publication date
BR112017025810A2 (pt) 2018-08-07
JP2018517816A (ja) 2018-07-05
US20180127560A1 (en) 2018-05-10
EP3302597A1 (en) 2018-04-11
US11118025B2 (en) 2021-09-14
CN107666915A (zh) 2018-02-06
US20160355661A1 (en) 2016-12-08
MX2017015577A (es) 2018-03-27
US9896560B2 (en) 2018-02-20
AU2016270495A1 (en) 2017-11-09
CA2988080A1 (en) 2016-12-08
AU2016270495B2 (en) 2020-07-16
WO2016196076A1 (en) 2016-12-08
JP6786525B2 (ja) 2020-11-18
MA44204A (fr) 2018-12-26
AU2016270495B9 (en) 2020-07-30

Similar Documents

Publication Publication Date Title
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
WO2015200722A3 (en) Devices, systems and methods for using and monitoring orthopedic hardware
EP3134038A4 (en) Spinal treatment devices, methods, and systems
PH12021550542A1 (en) Multivalent pneumococcal vaccines
EP3474861A4 (en) COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
EP3577156A4 (en) BLOCK COPOLYMERS OF LACTONES AND POLY (PROPYLENE FUMARATE)
FI3606567T3 (fi) Antibakteerisia biolääketieteellisiä implantteja ja niihin liittyviä materiaaleja, laitteita ja menetelmiä
EP3128953A4 (en) Implantable bone grafting devices, systems, and methods
EP3664751A4 (en) FULLY PATIENT SPECIFIC ORTHOPEDIC IMPLANTS AND IMPLANTATION DEVICES, SYSTEM AND MANUFACTURING OF THE SAME
MX2017000141A (es) Nanoparticulas terapeuticas dirigidas y metodos para elaborar y utilizar las mismas.
MA40535A (fr) Imagerie et thérapie d'une inflammation et d'une infection ciblant hsp90
MX2016012536A (es) Rnasa para su uso en el tratamiento o la prevencion de infecciones virales.
IL285371A (en) Treatment with gdf11 prevents weight gain, improves glucose loading and reduces hepatosteatosis
PH12018502318A1 (en) Compositions and methods for treatment of inflammation of infection of the eye
ZA202211980B (en) Methods and treatment of trauma
IL269546A (en) Lactic acid bacteria, methods and uses thereof
HUE043316T2 (hu) Eljárás polimer karbodiimidek elõállítására céziumsók hozzáadásával, polimer karbodiimidek és ezek alkalmazása
EA033806B9 (ru) Полимерный комплекс лекарственное средство-устройство, содержащий хинаголид, способ его изготовления, его применение и содержащий его набор
MX2017015577A (es) Espumas liofilizadas de polimeros absorbibles que contienen bloques de extremo.
EP3710526C0 (en) RESORBABLE IMPLANTABLE DEVICES BASED ON CROSS-LINKED GLYCOSAMINOGLYCANS AND METHOD FOR THE PRODUCTION THEREOF
MX2017015576A (es) Dispositivos medicos absorbibles basados en peliculas y espumas novedosas elaboradas a partir de copolimeros semicristalinos segmentados de lactida y epsilon-caprolactona que exhiben caracteristicas de absorcion a largo plazo.
SG10201806051XA (en) Compositions containing polymeric carbodiimide, epoxide and polyester-based polymers, their production and use
MX2016009523A (es) Articulo termoformado que contiene acido polilactico con d-lactida y proceso para su produccion.
EP3318289A4 (en) ABSORBABLE AND IMPLANTABLE IRON BASED MEDICINE PRODUCT AND MANUFACTURING METHOD THEREFOR
GB2543718A (en) An implant with improved surface properties and expansion means

Legal Events

Date Code Title Description
FG Grant or registration